logo

For the Inventor, By the Inventor

Ravi Bellamkonda

Columbus, OH, United States of America

Ravi Bellamkonda

LinkedIn

This inventor holds 18 USPTO granted patents and 6 published patent applications. Top assignees: Georgia Tech Research Corporation, Duke University, Children's Healthcare of Atlanta, Inc.. Active years: 1998-2026. Education: Osmania University (India); Brown University (USA); Massachusetts Institute of Technology (USA).

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ravi Bellamkonda. Retrieved from https://idiyas.com/inventor/ravi-bellamkonda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Graduated from:
  • Osmania University (India)
  • Brown University (USA)
  • Massachusetts Institute of Technology (USA)
USPTO Granted Patents = 18 

% Patents Active = 72.2

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 226(Granted Patents)


Location History:

  • Boston, MA (US) (1998 - 2000)
  • Twinsburg, OH (US) (2010)
  • Atlanta, GA (US) (2021)
  • Marietta, GA (US) (2010 - 2022)
  • Durham, NC (US) (2019 - 2024)

Company Filing History:

goldMedal5 out of 2,190 
 
Georgia Tech Research Corporation
 patents
silverMedal4 out of 2,078 
 
Duke University
 patents
bronzeMedal3 out of 87 
 
Children's Healthcare of Atlanta, Inc.
 patents
4. 2 out of 1,364 
 
Case Western Reserve University
 patents
5. 2 out of 1,024 
 
Emory University
 patents
6. 2 out of 2 
 
Marval Biosciences, Inc.
 patents
7. 2 out of 2 
 
Marval Pharma, Inc.
 patents
8. 1 out of 79 
 
Cleveland State University
 patents
9. 1 out of 32 
 
Cytotherapeutics, Inc.
 patents
10. 1 out of 23 
 
Neurotech S.a.
 patents
11. 2 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...
18 patents (USPTO):Explore Patents
1. 12558516 - Bi-directional access to tumors (2026-02-24),
2. 11998614 - Compositions and methods for inducing scarring by peri-tumoral cells (2024-06-04),
3. 11850372 - Bi-directional access to tumors (2023-12-26),
4. 11273250 - Devices, systems, and methods for excavating cancer cells (2022-03-15),
5. 10981007 - Systems, methods, and devices for neuromodulation (2021-04-20),
6. 10493233 - Bi-directional access to tumors (2019-12-03),
7. 9872834 - Nanocarrier therapy for treating invasive tumors (2018-01-23),
8. 9220682 - Nanocarrier therapy for treating invasive tumors (2015-12-29),
9. 8911708 - Nano-scale contrast agents and methods of use (2014-12-16),
10. RE45195 - Compositions and methods for enhancing contrast in imaging (2014-10-13),
11. 8652215 - Nanofilament scaffold for tissue regeneration (2014-02-18),
12. 8642013 - Nano-scale contrast agents and methods of use (2014-02-04),
13. 8357351 - Nano-scale contrast agents and methods of use (2013-01-22),
14. 7785568 - Compositions and methods for enhancing contrast in imaging (2010-08-31),
15. 7749496 - Neuronal regeneration (2010-07-06),
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…